Proton Radiation for Pancreatic Cancer Treatment

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Recruiting Phase 2 Interventional Study
Pancreatic Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Proton Collaborative Group · Research network
Who this trial is looking for

This trial is looking for patients with pancreatic cancer that cannot be surgically removed. Participants will receive proton radiation treatment along with oral chemotherapy.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with pancreatic cancer that cannot be removed.
  • I have borderline resectable or medically inoperable pancreatic cancer.
  • I am willing to use contraception if I can have children.
  • I have a biliary obstruction but have a drainage tube placed.
  • I meet the required lab test results.

You may not be able to join if

  • I have distant metastasis.
  • I have had surgery for my cancer before.
  • I have had another invasive cancer in the past 5 years.
  • I have an active or untreated infection.
  • I am pregnant or breastfeeding, or I cannot use contraception.
  • I have received radiation to my abdomen before.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resectable" disease treated with preoperative chemo-radiotherapy fair somewhat better - although many of these patients are not converted to resectability. It may be argued that intensification of local and regional therapy might 1.) Increase the…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Biopsy proven unresectable adenocarcinoma of the pancreas. * Have either unresectable, borderline resectable or medically inoperable carcinoma of the pancreas, or refusing surgery. * A biliary obstruction is able to participate as long as a drainage tube is in place prior to s…
Contacts

No contact information available.